ANTISENSE STRATEGY FOR DETERMINING RECEPTOR FUNCTION

Information

  • Research Project
  • 2188594
  • ApplicationId
    2188594
  • Core Project Number
    R43GM050627
  • Full Project Number
    1R43GM050627-01
  • Serial Number
    50627
  • FOA Number
  • Sub Project Id
  • Project Start Date
    1/1/1994 - 31 years ago
  • Project End Date
    6/30/1994 - 30 years ago
  • Program Officer Name
  • Budget Start Date
    1/1/1994 - 31 years ago
  • Budget End Date
    6/30/1994 - 30 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    12/27/1993 - 31 years ago

ANTISENSE STRATEGY FOR DETERMINING RECEPTOR FUNCTION

The use of oligonucleotide probes to modulate the synthesis of protein molecules has had important implications in understanding the growth of viruses and expression of oncogenes. More recently, antisense strategies have been employed in studies examining the nervous system. The applications of this methodology are numerous. Essentially, this technique represents a "knock-out" method by which the endogenous role of particular proteins.can be examined by both in vitro and in vivo investigations. We will develop this technology by designing oligonucleotide probes to the serotonin2 (5-HT2) receptor which represents a good model in which to define the parameters needed to achieve functional knockout. The system will be modelled in vitro using homogenous cell cultures expressing the rat 5-HT2 receptor. Subsequently, effective antisense probes will be administered to whole animals to determine behavioral and biochemical consequences of 5-HT2 receptor inactivation. The ultimate goal of this approach is to apply the technology to proprietory receptor sites to enable direction of conventional small molecule drug development by identifying potential therapeutic targets.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    SYNAPTIC PHARMACEUTICAL CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    PARAMUS
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    07652
  • Organization District
    UNITED STATES